BrightGene Bio-Medical Technology Co., Ltd.
BrightGene Bio-Medical Technology is a Suzhou-based company listed on Shanghai's STAR Market (SSE: 688166). Its weight-management injection BGM0504 had its NDA accepted in China in June 2026.
| Headquarters | Suzhou, China |
|---|---|
| Listing | SSE:688166 |
| Lead asset / stage | BGM0504 injection NDA accepted — China (weight management) |
| Latest event | BrightGene reported completion of its participation in CPHI Milan 2026. |